TIAA CREF Investment Management’s Stemline Therapeutics, Inc. STML Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $786K | Sell |
61,139
-34,977
| -36% | -$450K | ﹤0.01% | 2422 |
|
2018
Q4 | $913K | Buy |
96,116
+45,387
| +89% | +$431K | ﹤0.01% | 2321 |
|
2018
Q3 | $842K | Sell |
50,729
-1,670
| -3% | -$27.7K | ﹤0.01% | 2508 |
|
2018
Q2 | $841K | Sell |
52,399
-36,280
| -41% | -$582K | ﹤0.01% | 2560 |
|
2018
Q1 | $1.36M | Buy |
88,679
+38,237
| +76% | +$585K | ﹤0.01% | 2291 |
|
2017
Q4 | $787K | Sell |
50,442
-3,458
| -6% | -$54K | ﹤0.01% | 2579 |
|
2017
Q3 | $598K | Sell |
53,900
-3,162
| -6% | -$35.1K | ﹤0.01% | 2751 |
|
2017
Q2 | $525K | Sell |
57,062
-5,137
| -8% | -$47.3K | ﹤0.01% | 2846 |
|
2017
Q1 | $532K | Buy |
62,199
+7,888
| +15% | +$67.5K | ﹤0.01% | 2772 |
|
2016
Q4 | $581K | Sell |
54,311
-10,457
| -16% | -$112K | ﹤0.01% | 2789 |
|
2016
Q3 | $701 | Buy |
64,768
+318
| +0.5% | +$3 | ﹤0.01% | 2714 |
|
2016
Q2 | $436K | Buy |
64,450
+11,807
| +22% | +$79.9K | ﹤0.01% | 2924 |
|
2016
Q1 | $245K | Sell |
52,643
-7,986
| -13% | -$37.2K | ﹤0.01% | 2953 |
|
2015
Q4 | $383K | Sell |
60,629
-14,440
| -19% | -$91.2K | ﹤0.01% | 2966 |
|
2015
Q3 | $663K | Hold |
75,069
| – | – | ﹤0.01% | 2796 |
|
2015
Q2 | $884K | Buy |
75,069
+16,561
| +28% | +$195K | ﹤0.01% | 2754 |
|
2015
Q1 | $847K | Buy |
58,508
+14,393
| +33% | +$208K | ﹤0.01% | 2709 |
|
2014
Q4 | $753K | Buy |
44,115
+17
| +0% | +$290 | ﹤0.01% | 2811 |
|
2014
Q3 | $549K | Sell |
44,098
-2,983
| -6% | -$37.1K | ﹤0.01% | 2936 |
|
2014
Q2 | $691K | Buy |
47,081
+5,872
| +14% | +$86.2K | ﹤0.01% | 2917 |
|
2014
Q1 | $839K | Sell |
41,209
-1,330
| -3% | -$27.1K | ﹤0.01% | 2739 |
|
2013
Q4 | $834K | Buy |
42,539
+5,300
| +14% | +$104K | ﹤0.01% | 2780 |
|
2013
Q3 | $1.69M | Sell |
37,239
-10,564
| -22% | -$479K | ﹤0.01% | 2321 |
|
2013
Q2 | $1.14M | Buy |
+47,803
| New | +$1.14M | ﹤0.01% | 2506 |
|